Aprea Therapeutics Inc
XNAS: APRE
Aprea Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for sol...
Read More
1.54
-0.01
(-0.65%)
7,479
XNAS Volume
XNAS 10 Sep, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Aprea Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..